Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-01-30
2007-01-30
Chang, Celia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S123000
Reexamination Certificate
active
10722703
ABSTRACT:
The present invention provides compounds of the Formula I and II:wherein R1, R3, W, Z, X1, X2, Ar1, R8and R9are as defined herein, and methods and intermediates for their preparation and uses thereof.
REFERENCES:
patent: 4215216 (1980-07-01), Scotese et al.
patent: 5037826 (1991-08-01), Blythin et al.
patent: 5620981 (1997-04-01), Blankley et al.
patent: 5733913 (1998-03-01), Blankley et al.
patent: 5733914 (1998-03-01), Blankley et al.
patent: 5945422 (1999-08-01), Doherty et al.
patent: 6696566 (2004-02-01), Chen et al.
patent: 0 278 686 (1988-08-01), None
patent: 0 790 997 (2000-03-01), None
patent: 1078923 (2001-02-01), None
patent: 1078923 (2001-02-01), None
patent: 11 361 880 (2005-09-01), None
patent: WO 93/17682 (1993-09-01), None
patent: WO 96/15128 (1996-05-01), None
patent: WO 96/34867 (1996-11-01), None
patent: WO 97/13771 (1997-01-01), None
patent: WO 97/35539 (1997-10-01), None
patent: WO 97/35539 (1997-10-01), None
patent: WO 98/33798 (1998-08-01), None
patent: WO 98/46604 (1998-10-01), None
patent: WO 98/46605 (1998-10-01), None
patent: WO 99/61444 (1999-12-01), None
patent: WO 99/65908 (1999-12-01), None
Boehm & Adams, New Inhibitors of p38 Kinase, Exp. Opin. Ther. Patents 10(1):25-37 (2000).
Daboun et al., Reactions with Activated Nitriles: Some New Approaches to the Synthesis of Pyridine Derivatives, Heterocycles 19(10):1925-29 (1982).
Gavrin et al., Inhibition of Tp12 Kinase and TNF-alpha Production with 1,7-naphthyridine-3-carbonitriles: Synthesis and Structure-Activity Relationships, Bioorganic & Medicinal Chemistry Letters, 15:5288-5292 (2005).
Boschelli, et al, “Synthesis and Tyrosine Kinase Inhibitory Activity of a Series of 2-Amino-8H-pyrido[2,3-d]pyrimidines. Identification of Potent, Selective Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitors,”Journal of Med. Chem.,(1998), pp. 4365-4377, vol. 41.
Klutchko, et al., “2-Substituted Aminopyrido[2,3-d] pyrimidine-7(8H)-ones. Structure-Activity Relationships Against Selected Tyrosine Kinases and in Vitro and in Vivo Anticancer Activity,”Journal of Med. Chem.,(1998), pp. 3276-3292, vol. 41.
Barvian, et al., “Pyrido[2,3-d]pyrimidin-7-one Inhibitors of Cyclin-Dependent Kinases,”Journal of Med. Chem.,(2000), pp. 4606-4616, vol. 43.
Hamby, et al., “Structure-Activity Relationships for a Novel Series of Pyrido[2,3-d]pyrimidine Tyrosine Kinase Inhibitors,”Journal Med. Chem.,(1997), pp. 2296-2303, vol. 40.
Chen Jian Jeffrey
Dunn James Patrick
Goldstein David Michael
Stahl Christoph Martin
Balls R. James
Chang Celia
Hall Robert C.
Roche Palo Alto LLC
LandOfFree
6-substituted pyrido-pyrimidines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 6-substituted pyrido-pyrimidines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6-substituted pyrido-pyrimidines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3735539